• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALM
Click for more information
0.00% 0.8¢

ALMA METALS LIMITED - News & Media

Market Cap $12.34M  ! watchlist Created with Sketch. Add to my watchlist
Energy

Alma Metals Limited is an Australia-based metal exploration company. The Company... Alma Metals Limited is an Australia-based metal exploration company. The Company primarily explores for copper, and molybdenum. The Company’s projects include East Kimberley Copper Project, and Briggs Copper Project. The Briggs, Mannersley and Fig Tree Hill Porphyry Copper Project comprises three exploration permits for minerals (EPM) and one application for an EPM covering a total area of approximately 245 square kilometers. More

Articles & Videos

Alma Metals (ASX:ALM) continues drilling after updated Briggs resource exceeds 1Mt contained copper

Reporting live from the event, TMH's Mitchell Tinley is currently on the floor, accompanied by Alma Metal's (ASX:ALM) Managing Director Frazer Tabeart.

20 Sep 2023 10:38 (AEST)



(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.34M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 500000 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 4899166 7
View Market Depth
Last trade - 08.23am 02/10/2024 (20 minute delay) ?
ALM (ASX) Chart

Top Stories

Argent hits rockchips up to 24g/t gold at Trunkey Creek, NSW

Argent Minerals has unveiled rockchips containing gold grading up to 24g/t on-site its NSW-based Trunkey Creek project acreage.
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.